The implementation will occur as part of a multi-year agreement that aims to improve patient care by giving clinicians clinical decision-making support and access to data from relevant clinical trials.
Philips IntelliSpace Precision Medicine is a system that brings together genomic data, disease histology and patient phenotype to give clinicians a comprehensive picture of a patient.
The agreement between Miami Cancer Institute and Philips will also advance the former’s launch of the TruSight Tumor 170 next-generation sequencing testing service, in collaboration with Illumina and N-of-One. The Philips system will help with data capture and storage.
More articles on healthcare quality:
Why some hospitals are offering essential oils to surgery patients
Former CDC leader on bird flu threat: ‘We don’t know how the story’s going to end’
Hospitals send many patients home with ‘risky’ antibiotics, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
